Relevance. Type 2 diabetes mellitus (DM2) is a chronic disease that requires gradual intensification of therapy to control glycemia. Studies show that poor control lasts up to seven years, increasing the risk of complications and health care costs. Combination medications, such as fixed-dose combinations of basal insulin and GLP-1 receptor antagonists, provide greater improvements in glycemic control and convenience (one injection per day) without increasing the risk of hypoglycemia and body weight. Purpose. To compare the efficacy and safety of a fixed combination of insulin glargine 100 U/mL with lixisenatide 50 μg/mL (iGlarLixi) compared with human insulins used in basal-bolus therapy, such as Actrapid and Insulatard Materials and methods. The study included 30 patients with type 2 diabetes: 14 of them received the drug iGlarLixy Soliqua (group 1), and 16 received a combination of actrapid and insulatard (group 2). All participants took metformin in dosages ranging from 1000 to 2500 mg per day. Research methods: . Fasting and postprandial glycemia, glycated hemoglobin (HbA1c), lipid spectrum. Results. The results showed that the first group had a significant decrease in fasting blood glucose (from 8.7±0.87 to 6.2±0.58) compared to the second group (from 8.9±0.95 to 7.4±0. 67); postprandial glycemia (13.2±1.33 to 7.9±0.67) than with the second group (from 13.25±1.34 to 9.2±0.56); In patients of the first group, the average HbA1c level after 6 months was 7.78 ± 0.80% (p < 0.05), and after 12 months - 7.20 ± 0.83% (p < 0.001). In the second group, after 6 months, HbA1c was 8.23 ± 0.80%, and after 12 months - 7.69 ± 0.76% (p < 0.05). During 12 months of therapy, 1 patient (0.71%) of the first group experienced confirmed symptomatic hypoglycemia (glycemia ≤3.9 mmol/l); there were no severe cases. In the second group, 5 patients (16.7%) noted such hypoglycemia, also without severe cases. When analyzing the lipid spectrum in patients with type 2 diabetes, hyperlipoproteinemia was revealed, with a significant increase in indicators compared to the control group. Total cholesterol (TC) levels were 34% higher (P<0.05), LDL increased by 37.5%, and triglycerides (TG) by 40.6% (P<0.01). The HDL level was lower by 60.2% (P<0.05). These results confirm data from the literature on an increase in atherogenic lipoproteins and a decrease in the antiatherogenic fraction in patients with type 2 diabetes. Conclusion. Thus, due to the ability of Soliqua to quickly achieve target levels of glycemia and glycated hemoglobin and lipid spectrum, as well as its safety and good tolerability, it can be recommended as one of the drugs of choice among hypoglycemic agents for patients with type 2 diabetes and cardiovascular diseases .
| Mualliflar | Урунбаева Дилором Анваровна, Омонова Зилола Тохтамурод кизи |
|---|---|
| Jurnal | Марказий Осиё эндокринологик журнали |
| Nashr sanasi | 2025-01-24 |
| Jild | 4 |
| Son | 3 |
| Til | Rus |
сахарный диабет 2 типа, аналоги ГПП-1, Соликва СолоСтар, иГларЛикси, type 2 diabetes mellitus, GLP-1 analogues, Soliqua SoloStar, iGlarLixi, 2-tur qandli diabet, GLP-1 analoglari, Soliqua SoloStar, iGlarLixi
From numerous studies, it is known about the role of SGLT-2 inhibitors in reducing glycemia, cardio- and nephroprotection in patients with type 2 diabetes. SGLT-type 1 has been studied somewhat less, the management and…
Relevance. Graves' disease (GD) is a hereditary organ-specific autoimmune disorder. The incidence of GD in children has increased by 27.3-30.1% over the last 10-20 years, with a more pronounced rise in the last decade…
Endocrine ophthalmopathy is an autoimmune disease often associated with thyroid dysfunction. It affects the tissues of the orbit and periorbital structures, causing their edema and degenerative changes. One of the most…
Objective. Obesity has become a global epidemic, affecting more than 600 million people worldwide. WHO reports that in 2022, 2.5 billion adults (18 years and older) were overweight. Of these, 890 million were living…
Background. Research shows that excess weight negatively affects the development and progression of respiratory diseases. As the SARS-CoV-2 pandemic continues, it is important to understand how body mass index (BMI)…
Background. Ultrasound-based thyroid nodule risk stratification, such as TIRADS, was introduced to reduce intervention in the “global epidemic” of “overdiagnosis” of thyroid cancer…
Currently, thyroid gland (TG) diseases with nodular formations are widespread, and due to ultrasound examination, it is possible to detect even the smallest nodules. The prevalence rate among the elderly population…
Relevance: Obesity is a significant global health issue requiring effective treatment methods. This study evaluates the impact of liraglutide, a glucagon-like peptide-1 (GLP-1) agonist, on non-diabetic obese patients…
Diabetic retinopathy (DR) is recognised as the leading cause of blindness and low vision among people of working age. Diagnosis and grading of the disease is…
Objective: Current research suggests that bariatric surgery can improve depression, anxiety, and quality of life in many patients. However, in a minority of patients, psychological health remains unchanged or may worsen…